In a study of 3 hospitals in Massachusetts, more than a quarter of patient orders were considered partially defensive medicine, but they only accounted for 13% of costs.
In a study of 3 hospitals in Massachusetts, more than a quarter of patient orders were considered partially defensive medicine, but they only accounted for 13% of costs, according to a summary published in JAMA.
Defensive medicine is the overuse of tests and procedures because of fear of malpractice litigation, and it is estimated to cost $46 billion annually in the United States. According to the data compiled from 39 participating physicians at Baystate Medical Center, Baystate Franklin Medical Center, and Baystate Mary Lane Hospital, just 13% of hospital costs could be considered at least partially defensive.
The physicians were asked to look through their orders from the previous day and indicate on a 5-point scale (with 0 being “not at all defensive” and 4 being “completely defensive”) the extent to which each one was ordered primarily because of malpractice concerns.
Overall, there were 4215 orders for 769 patients. The physicians generated a median of 3 orders per patient and 97 per physician, and 28% were considered defensive. Only 4 out of the 39 physicians identified no defensive orders, while 21 rated at least 1 order as “mostly defensive.”
Being more defensive did not increase costs per patient, the authors found. Compared with physicians with fewer defensive orders, those with at least 10% defensive orders placed a similar number of orders (5.4 vs 4.9) and generated similar costs per patient ($1679 vs $1700).
Completely defensive orders represented 2.9% of hospital costs. According to the investigators, most costs were due to potentially unnecessary hospitalizations, which accounted for 82% of all defensive orders.
Based on the information on demographics and attitudes toward defensive medicine gathered on the physicians, there were no factors were associated with defensive orders or cost.
“Defensive medicine practices varied substantially, but physicians who wrote the most defensive orders spent less than those who wrote fewer such orders, highlighting the disconnect between physician beliefs about defensive medicine and their contribution to costs,” the authors concluded.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
April 25th 2024A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen